From complex GLP-1 agonists to tailored synthesis strategies, our expert teams guide your molecule from early development to full-scale production. Backed by a globally integrated CDMO network and over 20 years of peptide experience, we bring what matters most: scientific depth, operational agility, and consistent quality.
Your Partner for Complex Peptide APIs
With decades of experience, commercial-scale capacity, and immediate availability—TAPI is ready to support your peptide development and manufacturing needs.
Why TAPI for Peptides
Built for complexity. Backed by legacy. Ready to deliver.
20+ years of peptide development and manufacturing experience
Integrated global network across R&D and GMP sites
Proven track record with complex GLP-1 analogs like tirzepatide and semaglutide
Available capacity for peptide APIs and building blocks
Seamless scale-up: mg to multi-metric ton production
Full regulatory compliance for global submissions
Ready When You Are
"In our R&D team, we combine scientific creativity, cutting-edge peptide technologies, and strong analytical capabilities to support your peptide journey from idea to implementation. Our flexible mindset and deep scientific partnership ensure tailored solutions for your needs."
Head of Peptide Development
18 Years in TAPI
18 Years in TAPI
Peptides at TAPI
A Legacy of Delivering Results
Since 2020, TAPI has developed and manufactured 15 peptide programs—ranging from building blocks and stabilizers to starting materials and APIs. These projects have been delivered across multiple sites supporting both clinical and commercial needs. Our upstream and downstream capabilities span solid-phase, liquid-phase, and hybrid synthesis methods, all supported by continuous investment in infrastructure and talent.
Prior peptide production at TAPI
* Sodium caprate and propyl gallate, excipients for biologics (MOPS – (N-morpholino)-propanesulfonic acid)
Peptide 1
9 amino acids
Tens of kgPeptide 2
20 amino acids
Tens of kgPeptide 3
9 amino acids
Tens of kgPeptide 4
6 amino acids
Tens of kgPeptide 5
5 amino acids
Tens of kgPeptide 6
4 amino acids
Tens of kg* Collaborations with originators
Capabilities
Combining expert science with GMP-ready infrastructure to deliver what your peptide program needs most: flexibility, quality, and speed.
Varied Synthesis Approaches
Varied Synthesis Approaches
SPPS, LPPS, hybrid, and recombinant — tailored to your molecule.
Process Design Expertise
Process Design Expertise
End-to-end support across upstream and downstream steps.
PAT & Data-Driven Tools
PAT & Data-Driven Tools
Real-time monitoring + modeling tools guide process optimization.
Impurity Characterization
Impurity Characterization
Advanced analytical tools ensure purity, control, and compliance.
Integrated Development
Integrated Development
Analytical, MS&T, and project teams aligned under one roof.
Capacity
Scale Without Delay
With dedicated infrastructure across four peptide-focused sites, TAPI is equipped to support projects from clinical supply to commercial launch—backed by available GMP capacity and a clear roadmap for expansion
- 4 peptide-dedicated sites across Israel and Croatia
- GMP lines supporting both early-phase and commercial production
- Flexible batch sizes — from kg-scale to hundreds of kg
- Capacity enhancement underway to meet rising demand
- Dedicated lines for peptide APIs, building blocks, and intermediates
- Integrated QC, MS&T, solvent recovery on-site and project management
